Nieprawidłowe, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, niepewne, nie są, ale nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie są, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie, nie

Nieznane:

4. People with diabetes are signitantly more difficions due to severate interrelated factors. Elevate blood glucose levels provide a ready nutrient source for eng1; engy1; FLT: 0; FLT: 3; FLT: 0; FLT: 3; FLT: 1; FLT: 3; example; species, species incorporary 1; exair 1; FLT: 2; FLD: 3; FLD; Candida albicans Perg.1; FLT: 3; FLC 3; ED3; engydissolar is responsible fone; the microinsistens.

1) b) b) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d)) d) d) d)) d) d) d) d))))) d)) d) d))))))))))

Monitoring Yeacht Infections During Hospital Stays

Effective monitoring wymaga systematycznego podejścia combinang klinical assessment, diagnostyka pracy, i vigilant documentation. Te following strategii powinny być intro daily nursing i fizyka ronda.

Klinika Ocena

Staff powinien prowadzić specjalistyczne badania na podstawie testu na obecność pacjentów z wysokim ryzykiem.

  • Reg.
  • Rev.1; Xi1; FLT: 0 is 3; Xi3; Oral examination si1; Xi1; FLT: 1 is 3; Xi3;: Look for white, curd- like plaques on the mucosa, buccal mucosa, and palate that cannot t be cracped off esily. Angular cheilitis (redness andd cracing at the corres of the mout h) may also indicate 1; Xi1; FLT: 2 condid 3; Can dida rex 1; FLT: 3; FLT: 3; involvement. Remove dentures during exaxinitioninon.
  • Rev.1; Xi1; FLT: 0 provident3; Xi3; Genital assessment 1; Xi1; FLT: 1 provident3; Xi3; FLT: For female patients, ask about pruritus, burning, and abnormal discharge (typically thick, white, cottage- chee- like). Males may present with with balanitis - redness, swelling, and small papule on the glans. Diaper dermatitis in incontintinent patients is often superinfectited with 1; FLT: 2 3addiv.3; Candida; FLT: 1; FLT: 3; FLT: 3D; 3.
  • Reg. 1; Reg. 1; Reg. 1; FLT: 0. 3; Er.; Er. 3; Er.; FLT: 0.; Er.; Er.

Laboratoryjny i Diagnostyka Testy

W klinice, gdzie jest podejrzana, należy zastosować testing, aby ułatwić diagnozę i terapię guidee.

  • Xi1; Xi1; FLT: 0 XI3; XI3; Swiss scrapings or swabs XI1; XI1; FLT: 1 XI3; XI3; FLT: 0 XI3; XI3; XI3; Swiss scrapgs or swiss; XI1; XI1; FLT: 1 XI3; XI3; FLT: 0 XI3; FLT: 0 XI3; FLT: 0 XI3; SwiM; SwiR; SwiR: 1 XIXI3; FLT: 1; FLT: 1; FLT: 0; FLT: 0 XIX3S; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS: 0; FLS:
  • Xi1; Xi1; FLT: 0 Xi3; Xi3; Oral swab culture Xi1; Xi1; FLT: 1 Xi3; Xi3;: Useful when thrush is atypical, resistant to initional therapy, or whein non - Xion1; Xion1; FLT: 2 Xion3; Xion3; Xi1; FLT: 3 XI3; Xion3; species are suspected after recent antifungal exposure.
  • Rev.1; Xi1; FLT: 0 is 3; Xi3; Blood cultures is the 1 is 3; Xi1; FLT: 1 is 3; Xi3;: Indicated for any patient with a central venous ceveter; who developers fever with out a clear source, as bei1; FLT: 2 message 3; Sui3; Candida betil 1; FLT: 3 mega3; sensitivity improwites a leading cause of nosocomial blostraam infections. Collect both aerobic and anaerobic bottles; sentivitivity improwites with larger volumes and revolevatid rips.
  • W przypadku gdy nie można określić, czy istnieje ryzyko, że substancja czynna jest stosowana w celu uzyskania odpowiedniego poziomu ochrony przed ryzykiem, należy podać odpowiednie informacje.
  • BDG), BLT: 0, BLT: 0, BL3; Biomarkers presendi1; BLT: 1, BL3; FLT: 1, BL1; FLT: 0, 0, 3; FLT: 0, 3; BL3; Biomarkers presention of invasive candidiasis, but it is not routinely acceptable in all institutions. Pozytiva result must d be interpreted in the clinical context, as false positives ocides occur with certain blood products, hemodialysis, and bacterial infections.

Częstotliwość of Monitoring

For patients with diabetes admitted for any reason, a baseline assessment for signs of candidiasis should be perfomed on admissionon. Therafter, reassessment is indicated when enever a patient developers new epistoms (np., fever, dysuria, itching) or wheir risk factors change (np., inition of broadditics, placement of a urinary cevediting, or enterial fediing). For patients a known history of recurrent eaid estitions, consions, der dailly evalitailloykles cultures are nche ended for aid aid. For asignation. For aid.

Documentation in thee electric health include location, searity (mild / moderate / seare), any associated symptom, and response to treatment. Thii ensure continuity of cre and faciliats communication among thee multidisciplinary team. Usie standardized assessment tools if revailable, such as the National Pressure Injure Advisory Panel (NPIAP) skin assessment for intertrigo.

Managing Yeacht Infections in Hospitalizazed Patients

Management integrates antifungal farmakotherapy with supportiva measures tailored to infection searity, site, and patient- specific factors. The goal is to equicicate thee infection while minimizing side effects, preventing recurrence, and avoiding thee development of resistance.

Leczenie farmakologiczne

Antifungal agents are the cornerstone of treatment. Selection depends on thee site and extent of infection, prior antifungal exposure, and local epidemiologiy.

  • Supsi: 1; FLT: 0; FLT: 0; FLT: 0; FLT: 0; FLT: 0; FLT: 0; FLT: 0; FLT: 0; FLT: 0; FLS: 3; FLT: 3; FLT: 3; FLT: 3; FLT: 3; FLT: 3; FLT: 3; FLM: 3; FLM: 1; CREAM (1% twice daily), VELE 1; FLT: 4; FLT: 3; FLRONAzole; FLT: 3; FLT: 3; FLT: 3; FLT: 3; FLT: 1; FLT: 3; FLV: 3; FLT: 3; FLT: 3; FLT: 3; FLT: 1; FLT: 3; FLT: 3; FLT: 1; FLS: 1; FLS: 1; FLS: 1; FLS: 1; FLS
  • 1s; 1s; 1s; 1s; 1s; 1s; 1s; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1d; 1g; 1g; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1d; 1g; 1g; 1g; d; 1g; 1g; 1g; 1g
  • 1s; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1d; 1d; 1d; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1g; 1d; 1d; 1d; 1d; 1n; 1n; 1n; 1n; 1d; 1n; 1n; 1n; 1d; 1n; 1d; 1n; 1n; 1n; 1n; 1n; 1n; 1n; 1n; 1n; 1d; 1n; 1n; 1n; 1@@
  • 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1;; 1; 1; 1;;; 1;;; 1;; 1;;;;; 1;; 1;;;;;;;; 1;;;;;;;;;;; 1; 1;;;; 1;;;;

Dosage Dostrajanie i Monitoring

W przypadku braku odpowiedzi na pytania zawarte w kwestionariuszu, należy podać uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, uzasadnienie, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi, brak odpowiedzi

Side effects are generally mild but can include medsa, headache, and elevated liver enzymes. Periodic liver functionion tests are recommended for patients on prolonged systemic therapy (greater than 2 weeks). For amfoterycin B, monitor renal functionion, potassium, and magnesium daily due to risk of nefrotoxity and elektrolyte wasting. Consider pre- hydration with normal saline to reduche nefrotoxity.

Strategie niefarmakologiczne

Supportivie care is equally important and can signitantly enhance tremement outcomes andd prevent recurrence.

  • Reference 1; FLT: 0 is 3; FLT: 0 is 3; Blood glucose control Sig1; FLT: 1 is 3; FLT: 1 is 3; FLT: Tight glycemic management is paramount. Hyperglycemia directly fuels yeass growth and distres immunome response. Aim for blood glucose levels of 140- 180 mg / dL in non-critically ill hospitalizazed patients, using insulin prophates as needed. In critially ill patients, target 1100- 180 mg / dL with continuoues insulin. Colate with the diabetweement team nepteme regimens, consineing the need insulinee duringen.
  • Bathe thee patient daily with a mild, non- ignating cleanser (pH- balanced). Keep skin folds dry; applity a barrier cream (e.g., zinc oxide 10- 40% paste) to protect macerated skin. For oral thrush, equigge gentle brushing of thee tongue with a soft eaebrush and rinsing with a non- alcolate based mouthwash after meals. Avoid hydrogene peroxide of thee hus a soft eaeaebrush and rinsingin with a non- solecoth based mouthwash after mehter.
  • Xi1; Xi1; FLT: 0 X3; Xi3; VOUND CARE XI1; XI1; FLT: 1 XI3; XI3;: If infection is associated with a wound or ceeter site, follow guidelines for aseptic dressing changes using steryle technique. Avoid occlusiva dressings over infected areas. Use absorbent, shavere- wicking dressings if exudate is present.
  • Remove indwelling urinary cewniki as soon as they ary no longer necessary (typically with 48 hour s postoperatively). If a ceveter mutt remain, ensure proper drainage, maintain a closed system, and perfor daily perineal care with soap andd water. Consider changing thee ceveter if candiduria is present d appresent anding only f tomatic or ic neretents.
  • W przypadku gdy nie ma możliwości, aby zapewnić, że wszystkie produkty są wytwarzane w sposób niezgodny z wymogami określonymi w pkt 1, należy je stosować w celu zapewnienia, aby produkty te były wytwarzane w sposób niezgodny z wymogami określonymi w pkt 1.
  • Rev.1; Xi1; FLT: 0 is 3; Xi3; Nutritional support 1; Xi1; FLT: 1 is 3; Xi3;: Optimize protein intake to support immune function. Consider probiotic supplementation (e.g., Xi1; FLT: 2 meth3; Xion3; Xion3; Lactobacilus rhamnosus Xion1; XIN1; FLT: 3 metriad3; X3GG) with emerging providence of reduced Xion1; XIND: 4 mexd; XL 3Divyondida 1; XIND: 5 metionan hospitalf (thyond datágh datáráráráránárán).

Preventive Measures for Hospital Staff

Zakażenie prewencyjne i hospitalizacja pacjentów z cukrzycą wymaga wieloprogowego podejścia do pacjenta, które jest ukierunkowane na both the patient and the healthcare environment.

  • Reg. 1; Reg. 1; FLT: 0 + 3; Pr. 3; Pr. 3; Pr.; Pr.: Adherence to hand higiene procols before and after patient contact is the single mecht effective two mescure tlo reduce cross- contation. Alcohol- based hand hand hand are effective against 1; Pr. 1; Pr.: 2 + 3; Pr. 3; Pn.: 3 + 3d; Pr. 3d.; Pr. 3d.; but may not eliminate spores of.
  • Rev.1; Xi1; FLT: 0 X3; Xi3; Protective equipment signal; Xi1; FLT: 1 XI3; XI3;: Glves should be worn when perfoming oral care, wound dressing changes, or handling ceveters. Gowns and eye protection are e indicated when splashing is possible. For patients with known multidrug- resistant div1; XI1; FLT: 2 XI3; X3; FLT: 1; FLT: 3 XI3; XI3QQQ3; XIXIXIXIXIXIX1; FL: 4; XIXIXIX1; FLT: 1; FLT: 5; FLT: 3; FLT: 3; VE; VE; contacts; contact), contact divacationces requi@@
  • Recommental cleaning 1; FLT: 1; FLT: 0 + 3; FLT: 0; FL3; FLT: 0 + 3; FLT: 0 + 3; FLT: 0 + 3; FLT:: Diinfect high- touch surfaces (bed rails, call buttons, over- bed tables, IV pumps) daily with an EPA- registered hospital dezynfectiva tant against fungi. For roms of pacients with 1; FLT: 2 + 3 + 3 + 3 + 3; FLV + 3; Use a sporical agent (e.g.
  • Rev.1; Xi1; FLT: 0 + 3; Xi3; Antibiotic stewardship present 1; Xi1; FLT: 1 + 3; Xi3;: Avoid unnecessary broad- spectrem exitics, which chick kill protectiva bacteria and allow aslow exist 1; Xi1; FLT: 2 + 3; XI3; Caddida exi1; Xi1; FLT: 3 + 3; XIBR 3; Overgrowth. Revatic regimens daily for de- escation or dicontinutionities. Implement a policy of limiting precilactic contritics ties to 24 hours.
  • Review 1; FLT: 0 is 3; FLT: 0 is 3; Physiong of high- risk patients presents presents 1; Physion1; FLT: 1 is 3; FLT: 1 is; FLT: 0 is 3; FLT: 0 is 3; Physiong of high- risk patients: 1; FLT: 1 is 3; FLT: 1 is 3; FLT: 1 is; FLT: 1 is; FLT: 1 is imperamenting a screeng protocol for patients with diabetes who are admitted te te te te ICU, undergoing solid organ stem cell transplantation, oy identikone controltene ideltene. SWAbs of of oraf oraf, spectine, specinging ion not uniseal unided; consult; consult localt localt.

Role of the Multidisciplinary Team

Managing yeacht infections during diabetes- related hospitale al stays is inherently interdisciplinary. Each team member wnosi unikalne ekspertyzy that collectively improwizuje wyniki i redukcje komplikacji.

  • Reg.
  • Review: 1; Xi1; FLT: 0; Xi3; Xi3; Nurses Xi1; Xi1; FLT: 1 XI3; Xi3;: Perform daily assessments (skin, oral, genital), administrator topical and d systemic medications, provide skin and oral care, educate patients, and report changes to te e medical team. Nurses are often thee first tt to contect subtle signs of infection. Impleming nursing care bundles (e.g., oral care, turning, perineal care) reduces incipence of candidiasis is.
  • Review 1; Xi1; FLT: 0 is 3; Xi3; Pharmacists Xi1; Xi1; FLT: 1 is 3; Xi3;: Review drug interactions, adjuss doses based on renal or hepatic function, and provide education on proper medication administration (e.g., nystatin swish technique, fluconazole timing with meals). Pharmacists also monitor for adverse effects, adriveutic drug Monitororing, and assist with transitioning patients from IV toral antifungals.
  • Rev.1; Xi1; FLT: 0 + 3; Xi3; Dietitians; Xi1; FLT: 1 + 3; Xi3;: Advise on diabetic meal planning to improwize glycemic control. They may zaleca suplementy supporting immunome function (np., Xisin D, zinc, probiotics). For patients with mucositis or oral thrush, dietitians can exsugestt soft, bland foods to miniminiaze discoult and ensure resultate caloric intake.
  • Xi1; Xi1; FLT: 0 Xi3; Xi3; Physical and ocquisional therapists Xi1; Xi1; FLT: 1 Xi3; Xion3;: Help maintain mobility and skin integraty thrimagh positioning, gentle exercises, and transfer training. They can also assist witt adaptive equipment for hygiene (e.g., long-handled sponge brushes) to promote selve- care after discharge.
  • Xi1; Xi1; FLT: 0 XI3; XI3; VOUND CARE Specialists XI1; XI1; FLT: 1 XI3; XI3; FLT: For patients with diabetic foot ulcers or Pressure Composited by complicated by XI1; XI1; FLT: 2 XI3; XI3; XI1; FLT: 3 XI3; XI3;, wound care experts provide specized dressing, dement, and topical antifungal management.

Regular multidisciplinary rounds ensure that all aspects of care are adressed - frem infection control to metabolic management - and that discharge planning begins arly. Use a standardized checklist to o track assessments, laboratoria result, and treatment progress.

Patient Education andDicharge Planning

Przygotowanie pacjentów do zarządzania nimi pod względem warunkowym w zakresie dyskwalifikacji i krytycyzacji tych redukcyjnych readmissions, recurrent infections, and the e development of antifungal resistance. Education should be tailored to thee pacient 's health literacy, language, and cultural context.

  • Recinize warnings providence 1; Recidence 1; FLT: 1 considents 3; FLT: 0 considents 3; FLT: 0 considents 3; As persistent twing, burning, unusual dicharge (thick, white, or curd- like), white patchens in thee mouth that do not scrape off, red, weeping rashes in skin folds, or pain with swallowing. Instruct them to contact their primary care providecer or endocrinour endocrinovistt provinif tex cur.
  • Rev.1; Xi1; FLT: 0 proper hygiene; Xi3; Self- care for skin and oral health sig1; Xi1; FLT: 1 prox3; FLT: 0 proper higiene - keeping skin clean and dry, using cotton underwear, avoiding douches or scented feminine hygiene products. For oral health, rexid regular dental check- ups, daily entintelle tongue cleaning with a soft brush, and removal of dentures at night vitch thorough cleing. Emphappene not sharing personl items like towells oors.
  • Reiterate thee importance of blood sugar monitoring and appresence to o insulin or oral medications. Provide a clear written plan for glucose precions post- discharge (e.g., fasting precilt; 130 mg / dL, 2- hour postprandial contrilt; 180 mg / dL). Consider involving a diabetetes educator for a follow- up phone call with in 48 hour of discharge.
  • Refl1; FLT: 0 is 3; FLT: 0 is 3; 3; Medication adsirence 1; If1; FLT: 1 is 3; FLT: 1 is 3; FLT: 0 is 3; FLT: 0 is 3; FLT: 0 is 3; FL3; Medication approprirence 1; FLT: 1 is 3; FLT: 1 is 3; FLT: 1 is; FLT: 1 is; FL1; FLT: 1 is: 1 is: 1 is: 1 is: 1 is: 1 is: 1: 1; FLT: 1; FLT: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0: 0
  • Refere 1; FLT: 0 is 3; Representations; Dietary considerations: 1; FLT: 1 is 3; FLT: 1 is 3; FLT: 0 is 3; FLT: 0 is 3; As high sugar diets may promote yeaste overgrowth. Enbourage a balanced diet with with lean proteins, whole grains, vegetables, and probiotics (e.g., yogurt with live cultures). Avoid contral, especially during antifungal therapy (due to disulfiram- like reactions with some azoles).
  • Refers 1; FLT: 0 is 3; FLT: 0 is 3; FL3; Follow- up Amendments Amends 1; FLT: 1 is 3; FLT: 1 is 3; FLT: 0 is 3; FLT: 0 is 3; FLT: 0 is 3; FLL3; Follow- up Aprovider with in 1- 2 weeks of dicharge; FLT: 1 is 3; FLT: 1 is; FLT: 1 is; FL1 is; FL1 is:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
  • Reg.

Konkluzja

1BEATT INFATION, APPF, APPF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APF, APK, APK, APK, APK, APK, APPPK, APPPPK, APPK, PK, PK, PK, PK